Rationale, design, and methodology of a trial evaluating three models of care for #HCV treatment among injection drug users on #opioid agonist therapy https://t.co/k3L0aZ4cYT HT @EinsteinMed #HepatitisC #PWID #IDU #SUD https://t.co/VEJuyUHTSt
Rationale, design, and methodology of a trial evaluating three models of care for #HCV treatment among injection drug users on #opioid agonist therapy https://t.co/FS6LEfusAR HT @EinsteinMed #HepatitisC #PWID #IDU #SUD https://t.co/9v6YJXJQZz
Rationale, design, and methodology of a trial evaluating three models of care for #HCV treatment among injection drug users on #opioid agonist therapy https://t.co/WLdhMAw63r HT @EinsteinMed #HepatitisC #PWID #IDU #SUD https://t.co/uFeadZyM7H
Rationale, design, and methodology of a trial evaluating three models of care for #HCV treatment among injection drug users on #opioid agonist therapy https://t.co/4RfTjDqRS8 HT @EinsteinMed #HepatitisC #PWID #IDU #SUD https://t.co/AKKLBSaXSZ
Rationale, design, and methodology of a trial evaluating three models of care for #HCV treatment among injection drug users on #opioid agonist therapy https://t.co/pFHALALIH4 HT @EinsteinMed #HepatitisC #PWID #IDU #SUD https://t.co/qmfZRB9yQg
Rationale, design, and methodology of a trial evaluating three models of care for #HCV treatment among injection drug users on #opioid agonist therapy https://t.co/k3L0aZ4cYT HT @EinsteinMed #HepatitisC #PWID #IDU #SUD https://t.co/4MkzbUFKUz
Rationale, design, and methodology of a trial evaluating three models of care for #HCV treatment among injection drug users on #opioid agonist therapy https://t.co/4RfTjDqRS8 HT @EinsteinMed #HepatitisC #PWID #IDU #SUD https://t.co/5ksusigDgG
Rationale, design, and methodology of a trial evaluating three models of care for #HCV treatment among injection drug users on #opioid agonist therapy https://t.co/FS6LEfusAR HT @EinsteinMed #HepatitisC #PWID #IDU #SUD https://t.co/VaJpC9fsE7
Rationale, design, and methodology of a trial evaluating three models of care for #HCV treatment among injection drug users on #opioid agonist therapy https://t.co/WLdhMAw63r HT @EinsteinMed #HepatitisC #PWID #IDU #SUD https://t.co/4XetJQCicQ
RT @CHERISHresearch: Collaborators from @EinsteinMed and CHERISH @BruceSchackman and @BenjaminLinas describe the rationale, design, and met…
RT @CHERISHresearch: Collaborators from @EinsteinMed and CHERISH @BruceSchackman and @BenjaminLinas describe the rationale, design, and met…
Collaborators from @EinsteinMed and CHERISH @BruceSchackman and @BenjaminLinas describe the rationale, design, and methodology of a trial evaluating 3 models of care for #HCV treatment among #PWID on #opioid agonist therapy https://t.co/yMtVXks4LW
Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy https://t.co/VqiaPrWOKg #bmcinfectdis